- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Quantbot Technologies LP Reduces Johnson & Johnson Stake
Institutional investor sells over 35,000 shares of pharmaceutical giant
Mar. 6, 2026 at 10:25am
Got story updates? Submit your updates here. ›
Quantbot Technologies LP, an institutional investor, decreased its position in Johnson & Johnson (NYSE:JNJ) by 84.2% in the 3rd quarter, according to the company's recent 13F filing with the Securities and Exchange Commission (SEC). The firm now owns 6,653 shares of the company's stock, down from 41,991 shares previously.
Why it matters
Johnson & Johnson is a major pharmaceutical and consumer healthcare company, so changes in institutional ownership of its stock can provide insights into investor sentiment and market trends around the company.
The details
Quantbot Technologies LP sold 35,348 shares of Johnson & Johnson stock during the 3rd quarter, reducing its total holdings to 6,653 shares. The firm's position in JNJ was worth $1,234,000 at the end of the reporting period.
- Quantbot Technologies LP decreased its position in Johnson & Johnson in the 3rd quarter of 2026.
The players
Quantbot Technologies LP
An institutional investor that manages a portfolio of investments.
Johnson & Johnson
A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.
The takeaway
This transaction highlights the shifting investment landscape, as institutional investors adjust their portfolios in response to market conditions and their own investment strategies. The reduced stake in Johnson & Johnson by Quantbot Technologies LP may signal broader trends in the healthcare and pharmaceutical sectors that investors should monitor.
